1. Home
  2. ONEW vs CCCC Comparison

ONEW vs CCCC Comparison

Compare ONEW & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneWater Marine Inc.

ONEW

OneWater Marine Inc.

N/A

Current Price

$9.50

Market Cap

174.4M

ML Signal

N/A

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

N/A

Current Price

$2.78

Market Cap

185.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ONEW
CCCC
Founded
2014
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Auto & Home Supply Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
174.4M
185.1M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
ONEW
CCCC
Price
$9.50
$2.78
Analyst Decision
Buy
Strong Buy
Analyst Count
4
6
Target Price
$16.75
$12.20
AVG Volume (30 Days)
134.9K
2.7M
Earning Date
04-28-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.45
EPS
2.77
N/A
Revenue
$1,872,334,000.00
$35,947,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.27
N/A
P/E Ratio
$3.72
N/A
Revenue Growth
5.62
1.02
52 Week Low
$9.01
$1.09
52 Week High
$18.15
$3.82

Technical Indicators

Market Signals
Indicator
ONEW
CCCC
Relative Strength Index (RSI) 31.85 53.55
Support Level N/A $2.14
Resistance Level $12.51 N/A
Average True Range (ATR) 0.67 0.34
MACD -0.17 0.02
Stochastic Oscillator 14.44 38.82

Price Performance

Historical Comparison
ONEW
CCCC

About ONEW OneWater Marine Inc.

OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segments: Dealership and Distribution. The Dealership segment is involved in selling new and pre-owned boats. It also arranges financing and insurance products, provides repairs and maintenance services, offers marine-related parts and accessories, and supplies slip and storage accommodations at certain locations. The Distribution segment focuses on the manufacturing, assembly, and distribution of marine-related products. These products are supplied to distributors, box retailers, and online retailers through a network of warehouses and distribution centers. The company generates the majority of its revenue from the Dealership segment.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: